Does SATRALIZUMAB Cause Muscular weakness? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Muscular weakness have been filed in association with SATRALIZUMAB (Enspryng). This represents 8.7% of all adverse event reports for SATRALIZUMAB.
19
Reports of Muscular weakness with SATRALIZUMAB
8.7%
of all SATRALIZUMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is Muscular weakness From SATRALIZUMAB?
Of the 19 reports, 1 (5.3%) resulted in death, 16 (84.2%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SATRALIZUMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does SATRALIZUMAB Cause?
Neuromyelitis optica spectrum disorder (46)
Off label use (26)
Urinary tract infection (21)
Optic neuritis (15)
Hypoaesthesia (14)
Infection (14)
Pneumonia (13)
Covid-19 (11)
Fatigue (11)
Pain (11)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which SATRALIZUMAB Alternatives Have Lower Muscular weakness Risk?
SATRALIZUMAB vs SATRALIZUMAB-MWGE
SATRALIZUMAB vs SAXAGLIPTIN
SATRALIZUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SATRALIZUMAB vs SCOPOLAMINE
SATRALIZUMAB vs SCOPOLAMINE HYDROBROMIDE